AAREYDRUGS Stock Overview
Engages in the manufacture and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Aarey Drugs & Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹50.00 |
| 52 Week High | ₹68.00 |
| 52 Week Low | ₹27.90 |
| Beta | 0.92 |
| 1 Month Change | 3.41% |
| 3 Month Change | 3.41% |
| 1 Year Change | 77.94% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 15.34% |
Recent News & Updates
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Apr 15
Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Has A Pretty Healthy Balance Sheet
Mar 22Recent updates
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Apr 15Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Has A Pretty Healthy Balance Sheet
Mar 22What Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) P/E Is Not Telling You
Dec 30Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Shares Fly 25% But Investors Aren't Buying For Growth
Dec 29Calculating The Fair Value Of Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
Aug 20Shareholder Returns
| AAREYDRUGS | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.2% | 1.9% | 2.9% |
| 1Y | 77.9% | 62.5% | 45.3% |
Return vs Industry: AAREYDRUGS exceeded the Indian Pharmaceuticals industry which returned 62.5% over the past year.
Return vs Market: AAREYDRUGS exceeded the Indian Market which returned 45.3% over the past year.
Price Volatility
| AAREYDRUGS volatility | |
|---|---|
| AAREYDRUGS Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: AAREYDRUGS has not had significant price volatility in the past 3 months.
Volatility Over Time: AAREYDRUGS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | n/a | Mihir Ghatalia | www.aareydrugs.com |
Aarey Drugs & Pharmaceuticals Limited engages in the manufacture and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals.
Aarey Drugs & Pharmaceuticals Limited Fundamentals Summary
| AAREYDRUGS fundamental statistics | |
|---|---|
| Market cap | ₹1.43b |
| Earnings (TTM) | ₹28.89m |
| Revenue (TTM) | ₹3.48b |
49.6x
P/E Ratio0.4x
P/S RatioIs AAREYDRUGS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AAREYDRUGS income statement (TTM) | |
|---|---|
| Revenue | ₹3.48b |
| Cost of Revenue | ₹3.34b |
| Gross Profit | ₹144.11m |
| Other Expenses | ₹115.22m |
| Earnings | ₹28.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.03 |
| Gross Margin | 4.14% |
| Net Profit Margin | 0.83% |
| Debt/Equity Ratio | 31.4% |
How did AAREYDRUGS perform over the long term?
See historical performance and comparison